Cart
sales@molnova.com
PDE IV-IN-1
CAS No. 225100-12-9
PDE IV-IN-1( —— )
Catalog No. M32762 CAS No. 225100-12-9
PDE IV-IN-1 is a potent phosphodiesterase 4 (PDE4) inhibitor with anti-inflammatory activity for the treatment of asthma, chronic obstructive pulmonary disease and other inflammatory diseases, and is a potential compound for the study of depression.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 909 | Get Quote |
|
| 5MG | 1207 | Get Quote |
|
| 10MG | 1625 | Get Quote |
|
| 25MG | 2346 | Get Quote |
|
| 50MG | 3156 | Get Quote |
|
| 100MG | 4167 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePDE IV-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionPDE IV-IN-1 is a potent phosphodiesterase 4 (PDE4) inhibitor with anti-inflammatory activity for the treatment of asthma, chronic obstructive pulmonary disease and other inflammatory diseases, and is a potential compound for the study of depression.
-
DescriptionPDE IV-IN-1 is an inhibitor of phosphodiesterase IV, used for the research of asthma, COPD or other inflammatory diseases.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetPDE
-
RecptorPDE
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number225100-12-9
-
Formula Weight386.88
-
Molecular FormulaC20H23ClN4O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(N1C=2C(N=C1C)=C(C)N=C(Cl)N2)C3=CC(OC4CCCC4)=C(OC)C=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Purine derivative dihydrate, drugs containing the same as the active ingredient and intermediate in the production thereof. US 6919455 B2
molnova catalog
related products
-
Apremilast
Apremilast (CC-10004) is a potent, orally active PDE4 inhibitor with IC50 of 74 nM, inhibits TNF-α production in LPS-stimulated hPBMCs with IC50 of 77 nM.
-
Cilostamide
Cilostamide is a selective phosphodiesterase (PDE)3A and PDE3B inhibitor(IC50 values of 27 and 50 nM respectively).
-
Triflusal
Triflusal is a platelet aggregation inhibitor that was discovered and developed in the Uriach Laboratories, and commercialised in Spain since 1981.
